SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Regulatory News (PRM)

Share Price Information for Proteome (PRM)

Share Price is delayed by 15 minutes
Get Live Data
1.55    0.00 (0.00%)
Bid:
1.55
Ask:
1.93
Spread: 0.38 (24.516%)
Market Cap: £5.44m
PRM Live PriceLast checked at - London Stock Exchange

Intraday Proteome Share Chart

Directorate Change

30 Sep 2014 07:00

RNS Number : 9286S
Proteome Sciences PLC
30 September 2014
 



 

 

 

 

 

Proteome Sciences plc

("Proteome Sciences" or the "Company")

Appointment of new Finance Director

 

30th September, 2014 - The Board of Proteome Sciences is pleased to announce the appointment of Mr. Geoffrey Ellis as Finance Director with effect from 1st October. Mr. Geoffrey John Ellis, 53, is a chartered accountant with over 30 years' experience in a range of senior financial, operational, sales and business development roles. He spent 15 years at Walt Disney where he was Chief Financial Officer of the Network of Disney Channels in EMEA and Managing Director of Disney Chanel Scandinavia, Middle East and Emerging Markets.

In addition to a strong financial background, he brings considerable international sales, marketing and licensing expertise and a key part of his role will be managing and expanding our commercial sales and marketing in USA and Europe.

Mr. James Malthouse will remain as a director of the company until his retirement on 30th November, 2014.

Mr. Ellis was a director of Curzon ISC Limited until shortly before it was placed into voluntary liquidation in March 2011. He was also a director of Warren Close Residents Association (Esher) Limited at the time it was placed into voluntary liquidation in May 2013.

Other than disclosed above, the Company confirms that there is no further information required to be disclosed in accordance with paragraph (g) of Schedule 2 of the AIM Rules.

 

- Ends -

For further information please contact:

Proteome Sciences plc

Christopher Pearce, Executive Chairman

Dr. Ian Pike, Chief Operating Officer Tel: +44 (0)1932 865065

James Malthouse, Finance Director

 

Cenkos - Nominated Adviser

Stephen Keys/Mark Connelly /Callum Davidson Tel: +44 (0)20 7397 8900

 

finnCap - Joint Broker

Geoff Nash (Corporate Finance) Tel: +44 (0)20 7220 0500

Tony Quirke (Broking)

 

IKON Associates - Public Relations

Adrian Shaw Tel: +44 (0)1483 271291

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAVKLFLZKFFBBX
Date   Source Headline
28th Jun 20105:59 pmRNSCOMPLETION OF PLACING AND OVERSUBSCRIBED OPEN OFFE
18th Jun 20107:00 amRNSUpdate on warranty claim
17th Jun 20109:00 amRNSReport and Accounts
11th Jun 20107:00 amRNSPublication of Circular
8th Jun 201011:21 amRNSHolding(s) in Company
7th Jun 20104:40 pmRNSSecond Price Monitoring Extn
7th Jun 20104:35 pmRNSPrice Monitoring Extension
7th Jun 20104:22 pmRNSPreliminary Results
7th Jun 20104:17 pmRNSPlacing, Open Offer & Loan Conversion
2nd Jun 20107:00 amRNSReimbursement of lung cancer test in USA
26th Apr 201011:55 amRNSBlocklisting Interim Review
9th Apr 20107:00 amRNSLicense Agreement
11th Feb 20108:18 amRNSAlliance with Parexel
9th Feb 20107:00 amRNSChange of Adviser
1st Feb 20102:01 pmRNSHolding(s) in Company
23rd Dec 20093:55 pmRNSDirectorate Change
16th Nov 20091:39 pmRNSHolding(s) in Company
28th Oct 20097:00 amRNSRe Contract
26th Oct 20097:00 amRNSBlock Admission
23rd Oct 20094:40 pmRNSSecond Price Monitoring Extn
23rd Oct 20094:35 pmRNSPrice Monitoring Extension
30th Sep 20097:00 amRNSHalf Yearly Report
25th Sep 20094:40 pmRNSSecond Price Monitoring Extn
25th Sep 20094:35 pmRNSPrice Monitoring Extension
10th Sep 20094:40 pmRNSSecond Price Monitoring Extn
10th Sep 20094:35 pmRNSPrice Monitoring Extension
9th Sep 20094:40 pmRNSSecond Price Monitoring Extn
9th Sep 20094:35 pmRNSPrice Monitoring Extension
28th Aug 20094:40 pmRNSSecond Price Monitoring Extn
28th Aug 20094:35 pmRNSPrice Monitoring Extension
16th Jul 20093:39 pmRNSHolding(s) in Company
14th Jul 200910:26 amRNSResult of AGM
6th Jul 20097:00 amRNSLicensing Agreement
30th Jun 20094:40 pmRNSSecond Price Monitoring Extn
30th Jun 20094:35 pmRNSPrice Monitoring Extension
22nd Jun 20098:00 amRNSPosting of Report & Accounts
18th Jun 20097:00 amRNSPreliminary Results
27th May 20097:00 amRNSLicense Agreement in Brain Damage
5th May 20092:40 pmRNSHolding(s) in Company
28th Apr 20092:20 pmRNSBlocklisting Interim Review
30th Mar 20097:00 amRNSChange of Adviser
23rd Mar 200910:30 amRNSHolding(s) in Company
18th Mar 20094:55 pmRNSHolding(s) in Company
9th Mar 20097:00 amPRNISO 9001: 2008 Certification
26th Feb 200911:09 amPRNCorrection : Holding(s) in Company
26th Feb 20099:00 amPRNHolding(s) in Company
15th Jan 20094:41 pmRNSSecond Price Monitoring Extn
15th Jan 20094:35 pmRNSPrice Monitoring Extension
6th Jan 20099:57 amPRNTrading Statement
4th Dec 20084:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.